Global Nucleic Acid-based Therapeutics Market Growth (Status and Outlook) 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Nucleic Acid-based Therapeutics market size was valued at US$ 513.5 million in 2023. With growing demand in downstream market, the Nucleic Acid-based Therapeutics is forecast to a readjusted size of US$ 677.7 million by 2030 with a CAGR of 4.0% during review period.
The research report highlights the growth potential of the global Nucleic Acid-based Therapeutics market. Nucleic Acid-based Therapeutics are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Nucleic Acid-based Therapeutics. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Nucleic Acid-based Therapeutics market.
Gene therapy is a technique for correcting defective genes responsible for disease development. Nucleic acid-based molecules (deoxyribonucleic acid, complementary deoxyribonucleic acid, complete genes, ribonucleic acid, and oligonucleotides) are utilized as research tools within the broad borders of gene therapy and the emerging field of molecular medicine.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Nucleic Acid-based Therapeutics market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Nucleic Acid-based Therapeutics market. It may include historical data, market segmentation by Type (e.g., Anti-Sense And Anti-Gene, Short Inhibitory Sequences), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Nucleic Acid-based Therapeutics market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Nucleic Acid-based Therapeutics market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Nucleic Acid-based Therapeutics industry. This include advancements in Nucleic Acid-based Therapeutics technology, Nucleic Acid-based Therapeutics new entrants, Nucleic Acid-based Therapeutics new investment, and other innovations that are shaping the future of Nucleic Acid-based Therapeutics.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Nucleic Acid-based Therapeutics market. It includes factors influencing customer ' purchasing decisions, preferences for Nucleic Acid-based Therapeutics product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Nucleic Acid-based Therapeutics market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Nucleic Acid-based Therapeutics market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Nucleic Acid-based Therapeutics market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Nucleic Acid-based Therapeutics industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Nucleic Acid-based Therapeutics market.
Market Segmentation:
Nucleic Acid-based Therapeutics market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
According to our LPI (LP Information) latest study, the global Nucleic Acid-based Therapeutics market size was valued at US$ 513.5 million in 2023. With growing demand in downstream market, the Nucleic Acid-based Therapeutics is forecast to a readjusted size of US$ 677.7 million by 2030 with a CAGR of 4.0% during review period.
The research report highlights the growth potential of the global Nucleic Acid-based Therapeutics market. Nucleic Acid-based Therapeutics are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Nucleic Acid-based Therapeutics. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Nucleic Acid-based Therapeutics market.
Gene therapy is a technique for correcting defective genes responsible for disease development. Nucleic acid-based molecules (deoxyribonucleic acid, complementary deoxyribonucleic acid, complete genes, ribonucleic acid, and oligonucleotides) are utilized as research tools within the broad borders of gene therapy and the emerging field of molecular medicine.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Nucleic Acid-based Therapeutics market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Nucleic Acid-based Therapeutics market. It may include historical data, market segmentation by Type (e.g., Anti-Sense And Anti-Gene, Short Inhibitory Sequences), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Nucleic Acid-based Therapeutics market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Nucleic Acid-based Therapeutics market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Nucleic Acid-based Therapeutics industry. This include advancements in Nucleic Acid-based Therapeutics technology, Nucleic Acid-based Therapeutics new entrants, Nucleic Acid-based Therapeutics new investment, and other innovations that are shaping the future of Nucleic Acid-based Therapeutics.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Nucleic Acid-based Therapeutics market. It includes factors influencing customer ' purchasing decisions, preferences for Nucleic Acid-based Therapeutics product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Nucleic Acid-based Therapeutics market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Nucleic Acid-based Therapeutics market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Nucleic Acid-based Therapeutics market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Nucleic Acid-based Therapeutics industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Nucleic Acid-based Therapeutics market.
Market Segmentation:
Nucleic Acid-based Therapeutics market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
- Anti-Sense And Anti-Gene
- Short Inhibitory Sequences
- Gene Transfer Therapy
- Nucleoside Analogs
- Ribozymes
- Aptamers
- Hospitals
- Academic & Research Institutes
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Wave Life Sciences
- Imugene
- Caperna
- Phylogica
- Protagonist Therapeutics
- Benitec Biopharma
- EGEN
- BioMedica
- Transgene
- Copernicus Therapeutics
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Nucleic Acid-based Therapeutics Market Size 2019-2030
2.1.2 Nucleic Acid-based Therapeutics Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Nucleic Acid-based Therapeutics Segment by Type
2.2.1 Anti-Sense And Anti-Gene
2.2.2 Short Inhibitory Sequences
2.2.3 Gene Transfer Therapy
2.2.4 Nucleoside Analogs
2.2.5 Ribozymes
2.2.6 Aptamers
2.3 Nucleic Acid-based Therapeutics Market Size by Type
2.3.1 Nucleic Acid-based Therapeutics Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Nucleic Acid-based Therapeutics Market Size Market Share by Type (2019-2024)
2.4 Nucleic Acid-based Therapeutics Segment by Application
2.4.1 Hospitals
2.4.2 Academic & Research Institutes
2.5 Nucleic Acid-based Therapeutics Market Size by Application
2.5.1 Nucleic Acid-based Therapeutics Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Nucleic Acid-based Therapeutics Market Size Market Share by Application (2019-2024)
3 NUCLEIC ACID-BASED THERAPEUTICS MARKET SIZE BY PLAYER
3.1 Nucleic Acid-based Therapeutics Market Size Market Share by Players
3.1.1 Global Nucleic Acid-based Therapeutics Revenue by Players (2019-2024)
3.1.2 Global Nucleic Acid-based Therapeutics Revenue Market Share by Players (2019-2024)
3.2 Global Nucleic Acid-based Therapeutics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 NUCLEIC ACID-BASED THERAPEUTICS BY REGIONS
4.1 Nucleic Acid-based Therapeutics Market Size by Regions (2019-2024)
4.2 Americas Nucleic Acid-based Therapeutics Market Size Growth (2019-2024)
4.3 APAC Nucleic Acid-based Therapeutics Market Size Growth (2019-2024)
4.4 Europe Nucleic Acid-based Therapeutics Market Size Growth (2019-2024)
4.5 Middle East & Africa Nucleic Acid-based Therapeutics Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Nucleic Acid-based Therapeutics Market Size by Country (2019-2024)
5.2 Americas Nucleic Acid-based Therapeutics Market Size by Type (2019-2024)
5.3 Americas Nucleic Acid-based Therapeutics Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Nucleic Acid-based Therapeutics Market Size by Region (2019-2024)
6.2 APAC Nucleic Acid-based Therapeutics Market Size by Type (2019-2024)
6.3 APAC Nucleic Acid-based Therapeutics Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Nucleic Acid-based Therapeutics by Country (2019-2024)
7.2 Europe Nucleic Acid-based Therapeutics Market Size by Type (2019-2024)
7.3 Europe Nucleic Acid-based Therapeutics Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Nucleic Acid-based Therapeutics by Region (2019-2024)
8.2 Middle East & Africa Nucleic Acid-based Therapeutics Market Size by Type (2019-2024)
8.3 Middle East & Africa Nucleic Acid-based Therapeutics Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL NUCLEIC ACID-BASED THERAPEUTICS MARKET FORECAST
10.1 Global Nucleic Acid-based Therapeutics Forecast by Regions (2025-2030)
10.1.1 Global Nucleic Acid-based Therapeutics Forecast by Regions (2025-2030)
10.1.2 Americas Nucleic Acid-based Therapeutics Forecast
10.1.3 APAC Nucleic Acid-based Therapeutics Forecast
10.1.4 Europe Nucleic Acid-based Therapeutics Forecast
10.1.5 Middle East & Africa Nucleic Acid-based Therapeutics Forecast
10.2 Americas Nucleic Acid-based Therapeutics Forecast by Country (2025-2030)
10.2.1 United States Nucleic Acid-based Therapeutics Market Forecast
10.2.2 Canada Nucleic Acid-based Therapeutics Market Forecast
10.2.3 Mexico Nucleic Acid-based Therapeutics Market Forecast
10.2.4 Brazil Nucleic Acid-based Therapeutics Market Forecast
10.3 APAC Nucleic Acid-based Therapeutics Forecast by Region (2025-2030)
10.3.1 China Nucleic Acid-based Therapeutics Market Forecast
10.3.2 Japan Nucleic Acid-based Therapeutics Market Forecast
10.3.3 Korea Nucleic Acid-based Therapeutics Market Forecast
10.3.4 Southeast Asia Nucleic Acid-based Therapeutics Market Forecast
10.3.5 India Nucleic Acid-based Therapeutics Market Forecast
10.3.6 Australia Nucleic Acid-based Therapeutics Market Forecast
10.4 Europe Nucleic Acid-based Therapeutics Forecast by Country (2025-2030)
10.4.1 Germany Nucleic Acid-based Therapeutics Market Forecast
10.4.2 France Nucleic Acid-based Therapeutics Market Forecast
10.4.3 UK Nucleic Acid-based Therapeutics Market Forecast
10.4.4 Italy Nucleic Acid-based Therapeutics Market Forecast
10.4.5 Russia Nucleic Acid-based Therapeutics Market Forecast
10.5 Middle East & Africa Nucleic Acid-based Therapeutics Forecast by Region (2025-2030)
10.5.1 Egypt Nucleic Acid-based Therapeutics Market Forecast
10.5.2 South Africa Nucleic Acid-based Therapeutics Market Forecast
10.5.3 Israel Nucleic Acid-based Therapeutics Market Forecast
10.5.4 Turkey Nucleic Acid-based Therapeutics Market Forecast
10.5.5 GCC Countries Nucleic Acid-based Therapeutics Market Forecast
10.6 Global Nucleic Acid-based Therapeutics Forecast by Type (2025-2030)
10.7 Global Nucleic Acid-based Therapeutics Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Wave Life Sciences
11.1.1 Wave Life Sciences Company Information
11.1.2 Wave Life Sciences Nucleic Acid-based Therapeutics Product Offered
11.1.3 Wave Life Sciences Nucleic Acid-based Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Wave Life Sciences Main Business Overview
11.1.5 Wave Life Sciences Latest Developments
11.2 Imugene
11.2.1 Imugene Company Information
11.2.2 Imugene Nucleic Acid-based Therapeutics Product Offered
11.2.3 Imugene Nucleic Acid-based Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Imugene Main Business Overview
11.2.5 Imugene Latest Developments
11.3 Caperna
11.3.1 Caperna Company Information
11.3.2 Caperna Nucleic Acid-based Therapeutics Product Offered
11.3.3 Caperna Nucleic Acid-based Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Caperna Main Business Overview
11.3.5 Caperna Latest Developments
11.4 Phylogica
11.4.1 Phylogica Company Information
11.4.2 Phylogica Nucleic Acid-based Therapeutics Product Offered
11.4.3 Phylogica Nucleic Acid-based Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Phylogica Main Business Overview
11.4.5 Phylogica Latest Developments
11.5 Protagonist Therapeutics
11.5.1 Protagonist Therapeutics Company Information
11.5.2 Protagonist Therapeutics Nucleic Acid-based Therapeutics Product Offered
11.5.3 Protagonist Therapeutics Nucleic Acid-based Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Protagonist Therapeutics Main Business Overview
11.5.5 Protagonist Therapeutics Latest Developments
11.6 Benitec Biopharma
11.6.1 Benitec Biopharma Company Information
11.6.2 Benitec Biopharma Nucleic Acid-based Therapeutics Product Offered
11.6.3 Benitec Biopharma Nucleic Acid-based Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Benitec Biopharma Main Business Overview
11.6.5 Benitec Biopharma Latest Developments
11.7 EGEN
11.7.1 EGEN Company Information
11.7.2 EGEN Nucleic Acid-based Therapeutics Product Offered
11.7.3 EGEN Nucleic Acid-based Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 EGEN Main Business Overview
11.7.5 EGEN Latest Developments
11.8 BioMedica
11.8.1 BioMedica Company Information
11.8.2 BioMedica Nucleic Acid-based Therapeutics Product Offered
11.8.3 BioMedica Nucleic Acid-based Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 BioMedica Main Business Overview
11.8.5 BioMedica Latest Developments
11.9 Transgene
11.9.1 Transgene Company Information
11.9.2 Transgene Nucleic Acid-based Therapeutics Product Offered
11.9.3 Transgene Nucleic Acid-based Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Transgene Main Business Overview
11.9.5 Transgene Latest Developments
11.10 Copernicus Therapeutics
11.10.1 Copernicus Therapeutics Company Information
11.10.2 Copernicus Therapeutics Nucleic Acid-based Therapeutics Product Offered
11.10.3 Copernicus Therapeutics Nucleic Acid-based Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Copernicus Therapeutics Main Business Overview
11.10.5 Copernicus Therapeutics Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Nucleic Acid-based Therapeutics Market Size 2019-2030
2.1.2 Nucleic Acid-based Therapeutics Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Nucleic Acid-based Therapeutics Segment by Type
2.2.1 Anti-Sense And Anti-Gene
2.2.2 Short Inhibitory Sequences
2.2.3 Gene Transfer Therapy
2.2.4 Nucleoside Analogs
2.2.5 Ribozymes
2.2.6 Aptamers
2.3 Nucleic Acid-based Therapeutics Market Size by Type
2.3.1 Nucleic Acid-based Therapeutics Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Nucleic Acid-based Therapeutics Market Size Market Share by Type (2019-2024)
2.4 Nucleic Acid-based Therapeutics Segment by Application
2.4.1 Hospitals
2.4.2 Academic & Research Institutes
2.5 Nucleic Acid-based Therapeutics Market Size by Application
2.5.1 Nucleic Acid-based Therapeutics Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Nucleic Acid-based Therapeutics Market Size Market Share by Application (2019-2024)
3 NUCLEIC ACID-BASED THERAPEUTICS MARKET SIZE BY PLAYER
3.1 Nucleic Acid-based Therapeutics Market Size Market Share by Players
3.1.1 Global Nucleic Acid-based Therapeutics Revenue by Players (2019-2024)
3.1.2 Global Nucleic Acid-based Therapeutics Revenue Market Share by Players (2019-2024)
3.2 Global Nucleic Acid-based Therapeutics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 NUCLEIC ACID-BASED THERAPEUTICS BY REGIONS
4.1 Nucleic Acid-based Therapeutics Market Size by Regions (2019-2024)
4.2 Americas Nucleic Acid-based Therapeutics Market Size Growth (2019-2024)
4.3 APAC Nucleic Acid-based Therapeutics Market Size Growth (2019-2024)
4.4 Europe Nucleic Acid-based Therapeutics Market Size Growth (2019-2024)
4.5 Middle East & Africa Nucleic Acid-based Therapeutics Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Nucleic Acid-based Therapeutics Market Size by Country (2019-2024)
5.2 Americas Nucleic Acid-based Therapeutics Market Size by Type (2019-2024)
5.3 Americas Nucleic Acid-based Therapeutics Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Nucleic Acid-based Therapeutics Market Size by Region (2019-2024)
6.2 APAC Nucleic Acid-based Therapeutics Market Size by Type (2019-2024)
6.3 APAC Nucleic Acid-based Therapeutics Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Nucleic Acid-based Therapeutics by Country (2019-2024)
7.2 Europe Nucleic Acid-based Therapeutics Market Size by Type (2019-2024)
7.3 Europe Nucleic Acid-based Therapeutics Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Nucleic Acid-based Therapeutics by Region (2019-2024)
8.2 Middle East & Africa Nucleic Acid-based Therapeutics Market Size by Type (2019-2024)
8.3 Middle East & Africa Nucleic Acid-based Therapeutics Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL NUCLEIC ACID-BASED THERAPEUTICS MARKET FORECAST
10.1 Global Nucleic Acid-based Therapeutics Forecast by Regions (2025-2030)
10.1.1 Global Nucleic Acid-based Therapeutics Forecast by Regions (2025-2030)
10.1.2 Americas Nucleic Acid-based Therapeutics Forecast
10.1.3 APAC Nucleic Acid-based Therapeutics Forecast
10.1.4 Europe Nucleic Acid-based Therapeutics Forecast
10.1.5 Middle East & Africa Nucleic Acid-based Therapeutics Forecast
10.2 Americas Nucleic Acid-based Therapeutics Forecast by Country (2025-2030)
10.2.1 United States Nucleic Acid-based Therapeutics Market Forecast
10.2.2 Canada Nucleic Acid-based Therapeutics Market Forecast
10.2.3 Mexico Nucleic Acid-based Therapeutics Market Forecast
10.2.4 Brazil Nucleic Acid-based Therapeutics Market Forecast
10.3 APAC Nucleic Acid-based Therapeutics Forecast by Region (2025-2030)
10.3.1 China Nucleic Acid-based Therapeutics Market Forecast
10.3.2 Japan Nucleic Acid-based Therapeutics Market Forecast
10.3.3 Korea Nucleic Acid-based Therapeutics Market Forecast
10.3.4 Southeast Asia Nucleic Acid-based Therapeutics Market Forecast
10.3.5 India Nucleic Acid-based Therapeutics Market Forecast
10.3.6 Australia Nucleic Acid-based Therapeutics Market Forecast
10.4 Europe Nucleic Acid-based Therapeutics Forecast by Country (2025-2030)
10.4.1 Germany Nucleic Acid-based Therapeutics Market Forecast
10.4.2 France Nucleic Acid-based Therapeutics Market Forecast
10.4.3 UK Nucleic Acid-based Therapeutics Market Forecast
10.4.4 Italy Nucleic Acid-based Therapeutics Market Forecast
10.4.5 Russia Nucleic Acid-based Therapeutics Market Forecast
10.5 Middle East & Africa Nucleic Acid-based Therapeutics Forecast by Region (2025-2030)
10.5.1 Egypt Nucleic Acid-based Therapeutics Market Forecast
10.5.2 South Africa Nucleic Acid-based Therapeutics Market Forecast
10.5.3 Israel Nucleic Acid-based Therapeutics Market Forecast
10.5.4 Turkey Nucleic Acid-based Therapeutics Market Forecast
10.5.5 GCC Countries Nucleic Acid-based Therapeutics Market Forecast
10.6 Global Nucleic Acid-based Therapeutics Forecast by Type (2025-2030)
10.7 Global Nucleic Acid-based Therapeutics Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Wave Life Sciences
11.1.1 Wave Life Sciences Company Information
11.1.2 Wave Life Sciences Nucleic Acid-based Therapeutics Product Offered
11.1.3 Wave Life Sciences Nucleic Acid-based Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Wave Life Sciences Main Business Overview
11.1.5 Wave Life Sciences Latest Developments
11.2 Imugene
11.2.1 Imugene Company Information
11.2.2 Imugene Nucleic Acid-based Therapeutics Product Offered
11.2.3 Imugene Nucleic Acid-based Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Imugene Main Business Overview
11.2.5 Imugene Latest Developments
11.3 Caperna
11.3.1 Caperna Company Information
11.3.2 Caperna Nucleic Acid-based Therapeutics Product Offered
11.3.3 Caperna Nucleic Acid-based Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Caperna Main Business Overview
11.3.5 Caperna Latest Developments
11.4 Phylogica
11.4.1 Phylogica Company Information
11.4.2 Phylogica Nucleic Acid-based Therapeutics Product Offered
11.4.3 Phylogica Nucleic Acid-based Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Phylogica Main Business Overview
11.4.5 Phylogica Latest Developments
11.5 Protagonist Therapeutics
11.5.1 Protagonist Therapeutics Company Information
11.5.2 Protagonist Therapeutics Nucleic Acid-based Therapeutics Product Offered
11.5.3 Protagonist Therapeutics Nucleic Acid-based Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Protagonist Therapeutics Main Business Overview
11.5.5 Protagonist Therapeutics Latest Developments
11.6 Benitec Biopharma
11.6.1 Benitec Biopharma Company Information
11.6.2 Benitec Biopharma Nucleic Acid-based Therapeutics Product Offered
11.6.3 Benitec Biopharma Nucleic Acid-based Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Benitec Biopharma Main Business Overview
11.6.5 Benitec Biopharma Latest Developments
11.7 EGEN
11.7.1 EGEN Company Information
11.7.2 EGEN Nucleic Acid-based Therapeutics Product Offered
11.7.3 EGEN Nucleic Acid-based Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 EGEN Main Business Overview
11.7.5 EGEN Latest Developments
11.8 BioMedica
11.8.1 BioMedica Company Information
11.8.2 BioMedica Nucleic Acid-based Therapeutics Product Offered
11.8.3 BioMedica Nucleic Acid-based Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 BioMedica Main Business Overview
11.8.5 BioMedica Latest Developments
11.9 Transgene
11.9.1 Transgene Company Information
11.9.2 Transgene Nucleic Acid-based Therapeutics Product Offered
11.9.3 Transgene Nucleic Acid-based Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Transgene Main Business Overview
11.9.5 Transgene Latest Developments
11.10 Copernicus Therapeutics
11.10.1 Copernicus Therapeutics Company Information
11.10.2 Copernicus Therapeutics Nucleic Acid-based Therapeutics Product Offered
11.10.3 Copernicus Therapeutics Nucleic Acid-based Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Copernicus Therapeutics Main Business Overview
11.10.5 Copernicus Therapeutics Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Nucleic Acid-based Therapeutics Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Anti-Sense And Anti-Gene
Table 3. Major Players of Short Inhibitory Sequences
Table 4. Major Players of Gene Transfer Therapy
Table 5. Major Players of Nucleoside Analogs
Table 6. Major Players of Ribozymes
Table 7. Major Players of Aptamers
Table 8. Nucleic Acid-based Therapeutics Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 9. Global Nucleic Acid-based Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 10. Global Nucleic Acid-based Therapeutics Market Size Market Share by Type (2019-2024)
Table 11. Nucleic Acid-based Therapeutics Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 12. Global Nucleic Acid-based Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 13. Global Nucleic Acid-based Therapeutics Market Size Market Share by Application (2019-2024)
Table 14. Global Nucleic Acid-based Therapeutics Revenue by Players (2019-2024) & ($ Millions)
Table 15. Global Nucleic Acid-based Therapeutics Revenue Market Share by Player (2019-2024)
Table 16. Nucleic Acid-based Therapeutics Key Players Head office and Products Offered
Table 17. Nucleic Acid-based Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 18. New Products and Potential Entrants
Table 19. Mergers & Acquisitions, Expansion
Table 20. Global Nucleic Acid-based Therapeutics Market Size by Regions 2019-2024 & ($ Millions)
Table 21. Global Nucleic Acid-based Therapeutics Market Size Market Share by Regions (2019-2024)
Table 22. Global Nucleic Acid-based Therapeutics Revenue by Country/Region (2019-2024) & ($ millions)
Table 23. Global Nucleic Acid-based Therapeutics Revenue Market Share by Country/Region (2019-2024)
Table 24. Americas Nucleic Acid-based Therapeutics Market Size by Country (2019-2024) & ($ Millions)
Table 25. Americas Nucleic Acid-based Therapeutics Market Size Market Share by Country (2019-2024)
Table 26. Americas Nucleic Acid-based Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 27. Americas Nucleic Acid-based Therapeutics Market Size Market Share by Type (2019-2024)
Table 28. Americas Nucleic Acid-based Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 29. Americas Nucleic Acid-based Therapeutics Market Size Market Share by Application (2019-2024)
Table 30. APAC Nucleic Acid-based Therapeutics Market Size by Region (2019-2024) & ($ Millions)
Table 31. APAC Nucleic Acid-based Therapeutics Market Size Market Share by Region (2019-2024)
Table 32. APAC Nucleic Acid-based Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 33. APAC Nucleic Acid-based Therapeutics Market Size Market Share by Type (2019-2024)
Table 34. APAC Nucleic Acid-based Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 35. APAC Nucleic Acid-based Therapeutics Market Size Market Share by Application (2019-2024)
Table 36. Europe Nucleic Acid-based Therapeutics Market Size by Country (2019-2024) & ($ Millions)
Table 37. Europe Nucleic Acid-based Therapeutics Market Size Market Share by Country (2019-2024)
Table 38. Europe Nucleic Acid-based Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 39. Europe Nucleic Acid-based Therapeutics Market Size Market Share by Type (2019-2024)
Table 40. Europe Nucleic Acid-based Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 41. Europe Nucleic Acid-based Therapeutics Market Size Market Share by Application (2019-2024)
Table 42. Middle East & Africa Nucleic Acid-based Therapeutics Market Size by Region (2019-2024) & ($ Millions)
Table 43. Middle East & Africa Nucleic Acid-based Therapeutics Market Size Market Share by Region (2019-2024)
Table 44. Middle East & Africa Nucleic Acid-based Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 45. Middle East & Africa Nucleic Acid-based Therapeutics Market Size Market Share by Type (2019-2024)
Table 46. Middle East & Africa Nucleic Acid-based Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 47. Middle East & Africa Nucleic Acid-based Therapeutics Market Size Market Share by Application (2019-2024)
Table 48. Key Market Drivers & Growth Opportunities of Nucleic Acid-based Therapeutics
Table 49. Key Market Challenges & Risks of Nucleic Acid-based Therapeutics
Table 50. Key Industry Trends of Nucleic Acid-based Therapeutics
Table 51. Global Nucleic Acid-based Therapeutics Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 52. Global Nucleic Acid-based Therapeutics Market Size Market Share Forecast by Regions (2025-2030)
Table 53. Global Nucleic Acid-based Therapeutics Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 54. Global Nucleic Acid-based Therapeutics Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 55. Wave Life Sciences Details, Company Type, Nucleic Acid-based Therapeutics Area Served and Its Competitors
Table 56. Wave Life Sciences Nucleic Acid-based Therapeutics Product Offered
Table 57. Wave Life Sciences Nucleic Acid-based Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 58. Wave Life Sciences Main Business
Table 59. Wave Life Sciences Latest Developments
Table 60. Imugene Details, Company Type, Nucleic Acid-based Therapeutics Area Served and Its Competitors
Table 61. Imugene Nucleic Acid-based Therapeutics Product Offered
Table 62. Imugene Main Business
Table 63. Imugene Nucleic Acid-based Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 64. Imugene Latest Developments
Table 65. Caperna Details, Company Type, Nucleic Acid-based Therapeutics Area Served and Its Competitors
Table 66. Caperna Nucleic Acid-based Therapeutics Product Offered
Table 67. Caperna Main Business
Table 68. Caperna Nucleic Acid-based Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 69. Caperna Latest Developments
Table 70. Phylogica Details, Company Type, Nucleic Acid-based Therapeutics Area Served and Its Competitors
Table 71. Phylogica Nucleic Acid-based Therapeutics Product Offered
Table 72. Phylogica Main Business
Table 73. Phylogica Nucleic Acid-based Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 74. Phylogica Latest Developments
Table 75. Protagonist Therapeutics Details, Company Type, Nucleic Acid-based Therapeutics Area Served and Its Competitors
Table 76. Protagonist Therapeutics Nucleic Acid-based Therapeutics Product Offered
Table 77. Protagonist Therapeutics Main Business
Table 78. Protagonist Therapeutics Nucleic Acid-based Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 79. Protagonist Therapeutics Latest Developments
Table 80. Benitec Biopharma Details, Company Type, Nucleic Acid-based Therapeutics Area Served and Its Competitors
Table 81. Benitec Biopharma Nucleic Acid-based Therapeutics Product Offered
Table 82. Benitec Biopharma Main Business
Table 83. Benitec Biopharma Nucleic Acid-based Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 84. Benitec Biopharma Latest Developments
Table 85. EGEN Details, Company Type, Nucleic Acid-based Therapeutics Area Served and Its Competitors
Table 86. EGEN Nucleic Acid-based Therapeutics Product Offered
Table 87. EGEN Main Business
Table 88. EGEN Nucleic Acid-based Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 89. EGEN Latest Developments
Table 90. BioMedica Details, Company Type, Nucleic Acid-based Therapeutics Area Served and Its Competitors
Table 91. BioMedica Nucleic Acid-based Therapeutics Product Offered
Table 92. BioMedica Main Business
Table 93. BioMedica Nucleic Acid-based Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 94. BioMedica Latest Developments
Table 95. Transgene Details, Company Type, Nucleic Acid-based Therapeutics Area Served and Its Competitors
Table 96. Transgene Nucleic Acid-based Therapeutics Product Offered
Table 97. Transgene Main Business
Table 98. Transgene Nucleic Acid-based Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 99. Transgene Latest Developments
Table 100. Copernicus Therapeutics Details, Company Type, Nucleic Acid-based Therapeutics Area Served and Its Competitors
Table 101. Copernicus Therapeutics Nucleic Acid-based Therapeutics Product Offered
Table 102. Copernicus Therapeutics Main Business
Table 103. Copernicus Therapeutics Nucleic Acid-based Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 104. Copernicus Therapeutics Latest Developments
Table 1. Nucleic Acid-based Therapeutics Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Anti-Sense And Anti-Gene
Table 3. Major Players of Short Inhibitory Sequences
Table 4. Major Players of Gene Transfer Therapy
Table 5. Major Players of Nucleoside Analogs
Table 6. Major Players of Ribozymes
Table 7. Major Players of Aptamers
Table 8. Nucleic Acid-based Therapeutics Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 9. Global Nucleic Acid-based Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 10. Global Nucleic Acid-based Therapeutics Market Size Market Share by Type (2019-2024)
Table 11. Nucleic Acid-based Therapeutics Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 12. Global Nucleic Acid-based Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 13. Global Nucleic Acid-based Therapeutics Market Size Market Share by Application (2019-2024)
Table 14. Global Nucleic Acid-based Therapeutics Revenue by Players (2019-2024) & ($ Millions)
Table 15. Global Nucleic Acid-based Therapeutics Revenue Market Share by Player (2019-2024)
Table 16. Nucleic Acid-based Therapeutics Key Players Head office and Products Offered
Table 17. Nucleic Acid-based Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 18. New Products and Potential Entrants
Table 19. Mergers & Acquisitions, Expansion
Table 20. Global Nucleic Acid-based Therapeutics Market Size by Regions 2019-2024 & ($ Millions)
Table 21. Global Nucleic Acid-based Therapeutics Market Size Market Share by Regions (2019-2024)
Table 22. Global Nucleic Acid-based Therapeutics Revenue by Country/Region (2019-2024) & ($ millions)
Table 23. Global Nucleic Acid-based Therapeutics Revenue Market Share by Country/Region (2019-2024)
Table 24. Americas Nucleic Acid-based Therapeutics Market Size by Country (2019-2024) & ($ Millions)
Table 25. Americas Nucleic Acid-based Therapeutics Market Size Market Share by Country (2019-2024)
Table 26. Americas Nucleic Acid-based Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 27. Americas Nucleic Acid-based Therapeutics Market Size Market Share by Type (2019-2024)
Table 28. Americas Nucleic Acid-based Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 29. Americas Nucleic Acid-based Therapeutics Market Size Market Share by Application (2019-2024)
Table 30. APAC Nucleic Acid-based Therapeutics Market Size by Region (2019-2024) & ($ Millions)
Table 31. APAC Nucleic Acid-based Therapeutics Market Size Market Share by Region (2019-2024)
Table 32. APAC Nucleic Acid-based Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 33. APAC Nucleic Acid-based Therapeutics Market Size Market Share by Type (2019-2024)
Table 34. APAC Nucleic Acid-based Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 35. APAC Nucleic Acid-based Therapeutics Market Size Market Share by Application (2019-2024)
Table 36. Europe Nucleic Acid-based Therapeutics Market Size by Country (2019-2024) & ($ Millions)
Table 37. Europe Nucleic Acid-based Therapeutics Market Size Market Share by Country (2019-2024)
Table 38. Europe Nucleic Acid-based Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 39. Europe Nucleic Acid-based Therapeutics Market Size Market Share by Type (2019-2024)
Table 40. Europe Nucleic Acid-based Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 41. Europe Nucleic Acid-based Therapeutics Market Size Market Share by Application (2019-2024)
Table 42. Middle East & Africa Nucleic Acid-based Therapeutics Market Size by Region (2019-2024) & ($ Millions)
Table 43. Middle East & Africa Nucleic Acid-based Therapeutics Market Size Market Share by Region (2019-2024)
Table 44. Middle East & Africa Nucleic Acid-based Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 45. Middle East & Africa Nucleic Acid-based Therapeutics Market Size Market Share by Type (2019-2024)
Table 46. Middle East & Africa Nucleic Acid-based Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 47. Middle East & Africa Nucleic Acid-based Therapeutics Market Size Market Share by Application (2019-2024)
Table 48. Key Market Drivers & Growth Opportunities of Nucleic Acid-based Therapeutics
Table 49. Key Market Challenges & Risks of Nucleic Acid-based Therapeutics
Table 50. Key Industry Trends of Nucleic Acid-based Therapeutics
Table 51. Global Nucleic Acid-based Therapeutics Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 52. Global Nucleic Acid-based Therapeutics Market Size Market Share Forecast by Regions (2025-2030)
Table 53. Global Nucleic Acid-based Therapeutics Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 54. Global Nucleic Acid-based Therapeutics Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 55. Wave Life Sciences Details, Company Type, Nucleic Acid-based Therapeutics Area Served and Its Competitors
Table 56. Wave Life Sciences Nucleic Acid-based Therapeutics Product Offered
Table 57. Wave Life Sciences Nucleic Acid-based Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 58. Wave Life Sciences Main Business
Table 59. Wave Life Sciences Latest Developments
Table 60. Imugene Details, Company Type, Nucleic Acid-based Therapeutics Area Served and Its Competitors
Table 61. Imugene Nucleic Acid-based Therapeutics Product Offered
Table 62. Imugene Main Business
Table 63. Imugene Nucleic Acid-based Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 64. Imugene Latest Developments
Table 65. Caperna Details, Company Type, Nucleic Acid-based Therapeutics Area Served and Its Competitors
Table 66. Caperna Nucleic Acid-based Therapeutics Product Offered
Table 67. Caperna Main Business
Table 68. Caperna Nucleic Acid-based Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 69. Caperna Latest Developments
Table 70. Phylogica Details, Company Type, Nucleic Acid-based Therapeutics Area Served and Its Competitors
Table 71. Phylogica Nucleic Acid-based Therapeutics Product Offered
Table 72. Phylogica Main Business
Table 73. Phylogica Nucleic Acid-based Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 74. Phylogica Latest Developments
Table 75. Protagonist Therapeutics Details, Company Type, Nucleic Acid-based Therapeutics Area Served and Its Competitors
Table 76. Protagonist Therapeutics Nucleic Acid-based Therapeutics Product Offered
Table 77. Protagonist Therapeutics Main Business
Table 78. Protagonist Therapeutics Nucleic Acid-based Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 79. Protagonist Therapeutics Latest Developments
Table 80. Benitec Biopharma Details, Company Type, Nucleic Acid-based Therapeutics Area Served and Its Competitors
Table 81. Benitec Biopharma Nucleic Acid-based Therapeutics Product Offered
Table 82. Benitec Biopharma Main Business
Table 83. Benitec Biopharma Nucleic Acid-based Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 84. Benitec Biopharma Latest Developments
Table 85. EGEN Details, Company Type, Nucleic Acid-based Therapeutics Area Served and Its Competitors
Table 86. EGEN Nucleic Acid-based Therapeutics Product Offered
Table 87. EGEN Main Business
Table 88. EGEN Nucleic Acid-based Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 89. EGEN Latest Developments
Table 90. BioMedica Details, Company Type, Nucleic Acid-based Therapeutics Area Served and Its Competitors
Table 91. BioMedica Nucleic Acid-based Therapeutics Product Offered
Table 92. BioMedica Main Business
Table 93. BioMedica Nucleic Acid-based Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 94. BioMedica Latest Developments
Table 95. Transgene Details, Company Type, Nucleic Acid-based Therapeutics Area Served and Its Competitors
Table 96. Transgene Nucleic Acid-based Therapeutics Product Offered
Table 97. Transgene Main Business
Table 98. Transgene Nucleic Acid-based Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 99. Transgene Latest Developments
Table 100. Copernicus Therapeutics Details, Company Type, Nucleic Acid-based Therapeutics Area Served and Its Competitors
Table 101. Copernicus Therapeutics Nucleic Acid-based Therapeutics Product Offered
Table 102. Copernicus Therapeutics Main Business
Table 103. Copernicus Therapeutics Nucleic Acid-based Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 104. Copernicus Therapeutics Latest Developments
LIST OF FIGURES
Figure 1. Nucleic Acid-based Therapeutics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Nucleic Acid-based Therapeutics Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Nucleic Acid-based Therapeutics Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Nucleic Acid-based Therapeutics Sales Market Share by Country/Region (2023)
Figure 8. Nucleic Acid-based Therapeutics Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Nucleic Acid-based Therapeutics Market Size Market Share by Type in 2023
Figure 10. Nucleic Acid-based Therapeutics in Hospitals
Figure 11. Global Nucleic Acid-based Therapeutics Market: Hospitals (2019-2024) & ($ Millions)
Figure 12. Nucleic Acid-based Therapeutics in Academic & Research Institutes
Figure 13. Global Nucleic Acid-based Therapeutics Market: Academic & Research Institutes (2019-2024) & ($ Millions)
Figure 14. Global Nucleic Acid-based Therapeutics Market Size Market Share by Application in 2023
Figure 15. Global Nucleic Acid-based Therapeutics Revenue Market Share by Player in 2023
Figure 16. Global Nucleic Acid-based Therapeutics Market Size Market Share by Regions (2019-2024)
Figure 17. Americas Nucleic Acid-based Therapeutics Market Size 2019-2024 ($ Millions)
Figure 18. APAC Nucleic Acid-based Therapeutics Market Size 2019-2024 ($ Millions)
Figure 19. Europe Nucleic Acid-based Therapeutics Market Size 2019-2024 ($ Millions)
Figure 20. Middle East & Africa Nucleic Acid-based Therapeutics Market Size 2019-2024 ($ Millions)
Figure 21. Americas Nucleic Acid-based Therapeutics Value Market Share by Country in 2023
Figure 22. United States Nucleic Acid-based Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 23. Canada Nucleic Acid-based Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 24. Mexico Nucleic Acid-based Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 25. Brazil Nucleic Acid-based Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 26. APAC Nucleic Acid-based Therapeutics Market Size Market Share by Region in 2023
Figure 27. APAC Nucleic Acid-based Therapeutics Market Size Market Share by Type in 2023
Figure 28. APAC Nucleic Acid-based Therapeutics Market Size Market Share by Application in 2023
Figure 29. China Nucleic Acid-based Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 30. Japan Nucleic Acid-based Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 31. Korea Nucleic Acid-based Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 32. Southeast Asia Nucleic Acid-based Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 33. India Nucleic Acid-based Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 34. Australia Nucleic Acid-based Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 35. Europe Nucleic Acid-based Therapeutics Market Size Market Share by Country in 2023
Figure 36. Europe Nucleic Acid-based Therapeutics Market Size Market Share by Type (2019-2024)
Figure 37. Europe Nucleic Acid-based Therapeutics Market Size Market Share by Application (2019-2024)
Figure 38. Germany Nucleic Acid-based Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 39. France Nucleic Acid-based Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 40. UK Nucleic Acid-based Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 41. Italy Nucleic Acid-based Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 42. Russia Nucleic Acid-based Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 43. Middle East & Africa Nucleic Acid-based Therapeutics Market Size Market Share by Region (2019-2024)
Figure 44. Middle East & Africa Nucleic Acid-based Therapeutics Market Size Market Share by Type (2019-2024)
Figure 45. Middle East & Africa Nucleic Acid-based Therapeutics Market Size Market Share by Application (2019-2024)
Figure 46. Egypt Nucleic Acid-based Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 47. South Africa Nucleic Acid-based Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 48. Israel Nucleic Acid-based Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 49. Turkey Nucleic Acid-based Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 50. GCC Country Nucleic Acid-based Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 51. Americas Nucleic Acid-based Therapeutics Market Size 2025-2030 ($ Millions)
Figure 52. APAC Nucleic Acid-based Therapeutics Market Size 2025-2030 ($ Millions)
Figure 53. Europe Nucleic Acid-based Therapeutics Market Size 2025-2030 ($ Millions)
Figure 54. Middle East & Africa Nucleic Acid-based Therapeutics Market Size 2025-2030 ($ Millions)
Figure 55. United States Nucleic Acid-based Therapeutics Market Size 2025-2030 ($ Millions)
Figure 56. Canada Nucleic Acid-based Therapeutics Market Size 2025-2030 ($ Millions)
Figure 57. Mexico Nucleic Acid-based Therapeutics Market Size 2025-2030 ($ Millions)
Figure 58. Brazil Nucleic Acid-based Therapeutics Market Size 2025-2030 ($ Millions)
Figure 59. China Nucleic Acid-based Therapeutics Market Size 2025-2030 ($ Millions)
Figure 60. Japan Nucleic Acid-based Therapeutics Market Size 2025-2030 ($ Millions)
Figure 61. Korea Nucleic Acid-based Therapeutics Market Size 2025-2030 ($ Millions)
Figure 62. Southeast Asia Nucleic Acid-based Therapeutics Market Size 2025-2030 ($ Millions)
Figure 63. India Nucleic Acid-based Therapeutics Market Size 2025-2030 ($ Millions)
Figure 64. Australia Nucleic Acid-based Therapeutics Market Size 2025-2030 ($ Millions)
Figure 65. Germany Nucleic Acid-based Therapeutics Market Size 2025-2030 ($ Millions)
Figure 66. France Nucleic Acid-based Therapeutics Market Size 2025-2030 ($ Millions)
Figure 67. UK Nucleic Acid-based Therapeutics Market Size 2025-2030 ($ Millions)
Figure 68. Italy Nucleic Acid-based Therapeutics Market Size 2025-2030 ($ Millions)
Figure 69. Russia Nucleic Acid-based Therapeutics Market Size 2025-2030 ($ Millions)
Figure 70. Spain Nucleic Acid-based Therapeutics Market Size 2025-2030 ($ Millions)
Figure 71. Egypt Nucleic Acid-based Therapeutics Market Size 2025-2030 ($ Millions)
Figure 72. South Africa Nucleic Acid-based Therapeutics Market Size 2025-2030 ($ Millions)
Figure 73. Israel Nucleic Acid-based Therapeutics Market Size 2025-2030 ($ Millions)
Figure 74. Turkey Nucleic Acid-based Therapeutics Market Size 2025-2030 ($ Millions)
Figure 75. GCC Countries Nucleic Acid-based Therapeutics Market Size 2025-2030 ($ Millions)
Figure 76. Global Nucleic Acid-based Therapeutics Market Size Market Share Forecast by Type (2025-2030)
Figure 77. Global Nucleic Acid-based Therapeutics Market Size Market Share Forecast by Application (2025-2030)
Figure 1. Nucleic Acid-based Therapeutics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Nucleic Acid-based Therapeutics Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Nucleic Acid-based Therapeutics Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Nucleic Acid-based Therapeutics Sales Market Share by Country/Region (2023)
Figure 8. Nucleic Acid-based Therapeutics Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Nucleic Acid-based Therapeutics Market Size Market Share by Type in 2023
Figure 10. Nucleic Acid-based Therapeutics in Hospitals
Figure 11. Global Nucleic Acid-based Therapeutics Market: Hospitals (2019-2024) & ($ Millions)
Figure 12. Nucleic Acid-based Therapeutics in Academic & Research Institutes
Figure 13. Global Nucleic Acid-based Therapeutics Market: Academic & Research Institutes (2019-2024) & ($ Millions)
Figure 14. Global Nucleic Acid-based Therapeutics Market Size Market Share by Application in 2023
Figure 15. Global Nucleic Acid-based Therapeutics Revenue Market Share by Player in 2023
Figure 16. Global Nucleic Acid-based Therapeutics Market Size Market Share by Regions (2019-2024)
Figure 17. Americas Nucleic Acid-based Therapeutics Market Size 2019-2024 ($ Millions)
Figure 18. APAC Nucleic Acid-based Therapeutics Market Size 2019-2024 ($ Millions)
Figure 19. Europe Nucleic Acid-based Therapeutics Market Size 2019-2024 ($ Millions)
Figure 20. Middle East & Africa Nucleic Acid-based Therapeutics Market Size 2019-2024 ($ Millions)
Figure 21. Americas Nucleic Acid-based Therapeutics Value Market Share by Country in 2023
Figure 22. United States Nucleic Acid-based Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 23. Canada Nucleic Acid-based Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 24. Mexico Nucleic Acid-based Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 25. Brazil Nucleic Acid-based Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 26. APAC Nucleic Acid-based Therapeutics Market Size Market Share by Region in 2023
Figure 27. APAC Nucleic Acid-based Therapeutics Market Size Market Share by Type in 2023
Figure 28. APAC Nucleic Acid-based Therapeutics Market Size Market Share by Application in 2023
Figure 29. China Nucleic Acid-based Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 30. Japan Nucleic Acid-based Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 31. Korea Nucleic Acid-based Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 32. Southeast Asia Nucleic Acid-based Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 33. India Nucleic Acid-based Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 34. Australia Nucleic Acid-based Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 35. Europe Nucleic Acid-based Therapeutics Market Size Market Share by Country in 2023
Figure 36. Europe Nucleic Acid-based Therapeutics Market Size Market Share by Type (2019-2024)
Figure 37. Europe Nucleic Acid-based Therapeutics Market Size Market Share by Application (2019-2024)
Figure 38. Germany Nucleic Acid-based Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 39. France Nucleic Acid-based Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 40. UK Nucleic Acid-based Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 41. Italy Nucleic Acid-based Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 42. Russia Nucleic Acid-based Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 43. Middle East & Africa Nucleic Acid-based Therapeutics Market Size Market Share by Region (2019-2024)
Figure 44. Middle East & Africa Nucleic Acid-based Therapeutics Market Size Market Share by Type (2019-2024)
Figure 45. Middle East & Africa Nucleic Acid-based Therapeutics Market Size Market Share by Application (2019-2024)
Figure 46. Egypt Nucleic Acid-based Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 47. South Africa Nucleic Acid-based Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 48. Israel Nucleic Acid-based Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 49. Turkey Nucleic Acid-based Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 50. GCC Country Nucleic Acid-based Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 51. Americas Nucleic Acid-based Therapeutics Market Size 2025-2030 ($ Millions)
Figure 52. APAC Nucleic Acid-based Therapeutics Market Size 2025-2030 ($ Millions)
Figure 53. Europe Nucleic Acid-based Therapeutics Market Size 2025-2030 ($ Millions)
Figure 54. Middle East & Africa Nucleic Acid-based Therapeutics Market Size 2025-2030 ($ Millions)
Figure 55. United States Nucleic Acid-based Therapeutics Market Size 2025-2030 ($ Millions)
Figure 56. Canada Nucleic Acid-based Therapeutics Market Size 2025-2030 ($ Millions)
Figure 57. Mexico Nucleic Acid-based Therapeutics Market Size 2025-2030 ($ Millions)
Figure 58. Brazil Nucleic Acid-based Therapeutics Market Size 2025-2030 ($ Millions)
Figure 59. China Nucleic Acid-based Therapeutics Market Size 2025-2030 ($ Millions)
Figure 60. Japan Nucleic Acid-based Therapeutics Market Size 2025-2030 ($ Millions)
Figure 61. Korea Nucleic Acid-based Therapeutics Market Size 2025-2030 ($ Millions)
Figure 62. Southeast Asia Nucleic Acid-based Therapeutics Market Size 2025-2030 ($ Millions)
Figure 63. India Nucleic Acid-based Therapeutics Market Size 2025-2030 ($ Millions)
Figure 64. Australia Nucleic Acid-based Therapeutics Market Size 2025-2030 ($ Millions)
Figure 65. Germany Nucleic Acid-based Therapeutics Market Size 2025-2030 ($ Millions)
Figure 66. France Nucleic Acid-based Therapeutics Market Size 2025-2030 ($ Millions)
Figure 67. UK Nucleic Acid-based Therapeutics Market Size 2025-2030 ($ Millions)
Figure 68. Italy Nucleic Acid-based Therapeutics Market Size 2025-2030 ($ Millions)
Figure 69. Russia Nucleic Acid-based Therapeutics Market Size 2025-2030 ($ Millions)
Figure 70. Spain Nucleic Acid-based Therapeutics Market Size 2025-2030 ($ Millions)
Figure 71. Egypt Nucleic Acid-based Therapeutics Market Size 2025-2030 ($ Millions)
Figure 72. South Africa Nucleic Acid-based Therapeutics Market Size 2025-2030 ($ Millions)
Figure 73. Israel Nucleic Acid-based Therapeutics Market Size 2025-2030 ($ Millions)
Figure 74. Turkey Nucleic Acid-based Therapeutics Market Size 2025-2030 ($ Millions)
Figure 75. GCC Countries Nucleic Acid-based Therapeutics Market Size 2025-2030 ($ Millions)
Figure 76. Global Nucleic Acid-based Therapeutics Market Size Market Share Forecast by Type (2025-2030)
Figure 77. Global Nucleic Acid-based Therapeutics Market Size Market Share Forecast by Application (2025-2030)
More Publications
Global Isoproterenol Hydrochloride Market Growth 2024-2030
US$ 3,660.00
December 2024
113 pages
Global Extracorporeal Membrane Oxygenation (ECMO) Outsourcing Service Market Growth (Status and Outlook) 2025-2031
US$ 3,660.00
September 2025
84 pages
Global Banana Milk Market Growth 2024-2030
US$ 3,660.00
May 2024
130 pages
Global Hyaluronic Acid (HA) for Medical Market Growth 2024-2030
US$ 3,660.00
March 2024
95 pages
Global Bi-level Pressure Devices Market Growth 2023-2029
US$ 3,660.00
February 2023
108 pages
